Chester County News and Community Website
EXTON, PA — Lungpacer Medical Inc. is commercializing an FDA-approved diaphragm stimulation system at U.S. hospitals to help critically ill patients discontinue mechanical ventilation, positioning its technology to address complications …
Lungpacer Expands ICU Reach With FDA-Approved Breathing Device Read More
EXTON, PA — Lungpacer Medical says physicians at one of the nation’s largest healthcare systems have completed the first commercial procedures using its FDA-approved AeroPace System, marking a pivotal step …
ICU Breakthrough: First Patients Breathe Free With Lungpacer’s AeroPace Read More EXTON, PA — Lungpacer Medical announced the enrollment of the first six patients in its landmark STARI (STimulation to Activate RespIration) clinical trial, a study evaluating the company’s next-generation AeroNova …
Lungpacer Launches Pivotal STARI Trial to Transform Critical Care Recovery Read More EXTON, PA — Lungpacer Medical, Inc. has announced pivotal results from the RESCUE-3 trial, published in the American Journal of Respiratory and Critical Care Medicine, showcasing the groundbreaking benefits of …
Lungpacer Medical Publishes Landmark Findings on AeroPace System in Critical Care Read More EXTON, PA — Lungpacer Medical is set to make a significant impact at the ATS 2025 International Conference in San Francisco, where the company will present breakthroughs in interventional therapies …
Lungpacer Medical to Present Innovative Research at ATS 2025 Read More EXTON, PA — Lungpacer Medical has unveiled promising results from its groundbreaking STIMULUS trial, a Phase 1 study conducted in collaboration with Toronto General Hospital. Presented at the 2025 Transcatheter Heart …
Lungpacer Medical Shares Promising Results from STIMULUS Trial Read More